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Summary
The Brassica rapa hairy root based expression platform, a turnip hairy root based expression
system, is able to produce human complex glycoproteins such as the alpha—L—iduronidase
(IDUA) with an activity similar to the one produced by Chinese Hamster Ovary (CHO) cells. In this
article, a particular attention has been paid to the N- and O-glycosylation that characterize the
alpha-L-iduronidase produced using this hairy root based system. This analysis showed that the
recombinant protein is characterized by highly homogeneous post translational profiles enabling
a strong batch to batch reproducibility. Indeed, on each of the 6 N-glycosylation sites of the
IDUA, a single N-glycan composed of a core Man3GlcNAc2 carrying one beta(1,2)-xylose and one
alpha(1,3)-fucose epitope (M3XFGN2) was identified, highlighting the high homogeneity of the
production system. Hydroxylation of proline residues and arabinosylation were identified during
O-glycosylation analysis, still with a remarkable reproducibility. This platform is thus positioned as
an effective and consistent expression system for the production of human complex therapeutic
proteins.
Introduction
To date, various recombinant protein expression systems have
been developed. This can be explained by the constraints that
each of these systems impose: inability to produce and/or secrete
functional complex proteins (e.g.: bacterial systems), existence of
a risk of viral transmission and toxic molecules (e.g.: bacterial
systems, mammalian cells), societal rejection (e.g.: GMO plants in
fields), or high production costs (e.g.: mammalian cells). Thus,
overall, all of the existing production systems present some
limitations.
Since more than 25 years, the transgenic plants have appeared
as an alternative system for the production of heterologous
recombinant therapeutic proteins offering a number of major
advantages as compared to the usual production from industrial
cell lines among which, in particular, the absence of potential
contamination by animal pathogens and the possibility of mass
production at low cost. However, the culture of transgenic plants
in open fields or in greenhouses is associated with numerous
limitations such as social rejection or environmental influence.
This has led the scientific community to develop plant alternatives
combining the intrinsic advantages of plants and a possible
production confinement. In this context, the hairy root expression
system appears as an obvious favourable candidate.
Hairy roots emerge from the wounding site of plantlets after
the infection by a symbiotic bacterium called Rhizobium rhizoge-
nes. In nature, this phenomenon is beneficial for the infected
plants as it enables them to extract more soil nutrients and water.
For its counterpart, the bacterium builds an environment
favourable to its development. These additional not adventitious
roots possess the quality to grow indefinitely and without
geotropism.
Hairy roots have been widely studied and used for the
production of specialized/secondary metabolites of industrial
and pharmaceutical interest (Georgiev et al., 2007; Giri and
Narasu, 2000; Guillon et al., 2006a,b; Srivastava and Srivastava,
2007). Since the 1990s, the production of recombinant proteins
has been considered as another promising application of hairy
root cultures. The first proof of concept was achieved by
producing a mouse monoclonal antibody by hairy roots of
tobacco plants (Wongsamuth and Doran, 1997). It was shown
that this antibody was secreted and accumulated in the culture
medium. Other recombinant proteins have been produced and
secreted by tobacco hairy roots, including the green fluorescent
protein (Medina-Bolıvar and Cramer, 2004), the murine inter-
leukin (Liu et al., 2009), the human acetylcholinesterase (Woods
et al., 2008) or the thaumatin sweetener (Pham et al., 2012). In
order to improve the hairy-root based expression system, a plant
species from the Brassicaceae family was especially selected
because it met certain criteria like use of an edible plant to avoid
any risk of known toxicity and high heterologous protein
secretion capacity by transformed roots (Huet et al., 2014). In
addition, the hairy roots that emerge from Brassica rapa can grow
indefinitely, which is not the case for the hairy roots that emerge
from Nicotiana benthamiana for example (Huet et al., 2014).
Using this system, complex recombinant proteins can be pro-
duced (Ele Ekouna et al., 2017). In the present article, the in-
depth characterization of one of such recombinant protein,
referred to as ‘rIDUA_RLT’ (for recombinant alpha-L-iduronida-
se_Root Lines Technology), is described.
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The alpha-L-iduronidase (IDUA) is a complex human glycopro-
tein which deficiency leads to the development of the
mucopolysaccharidosis type I (MPS I), a progressive lysosomal
storage disorder. Alpha-L-iduronidase (IDUA; EC 3.2.1.76) is a
71 kDa lysosomal enzyme that hydrolyses the terminal alpha-L-
iduronic acid residues of the glycosaminoglycans, such as
dermatan sulphate and heparan sulphate. IDUA is a secreted
protein presenting a signal peptide (1M-23A) which is released in
its final secreted form and six potential N-glycosylation sites as
well as hydroxylation. Such protein have already being produced
in plants (Acosta et al., 2015; He et al., 2012, 2013; Pierce et al.,
2017) and in CHO cells (Aldurazyme, Sanofi, Paris, France;
Kakkis et al., 1994). This gave the opportunity to compare the
characteristics of the rIDUA_RLT protein produced in hairy root
clones with its benchmark produced by using a mammalian-
based production system or other production systems.
Here, in order to biochemically characterize the protein
produced by this hairy roots based expression platform, we
analysed its activity as well as its post-translational modifications.
As most of the biopharmaceuticals are glycosylated proteins
(Walsh and Jefferis, 2006) and as it is well-established that the
glycosylation of these recombinant proteins are essential for their
biological activity, safety, efficacy and immunogenicity (van Beers
and Bardor, 2012; Lingg et al., 2012), a particular attention was
paid to the analysis of both the N- and O-glycosylation profiles of
the protein produced using the hairy root-based expression
system.
Results
Transformed turnip hairy root clones are able to
reproducibly secrete an active rIDUA_RLT recombinant
protein that can be purified using a customized process
Turnip plantlets were infected with transformed R. rhizogenes
containing the plasmid pRD400-SP-IDUA as described previ-
ously (Huet et al., 2014). One hundred and fifty-three hairy
root clones emerged from the wounding sites. These clones
were individualized and cultured first in solid and then in
liquid media. At this stage, 39 hairy root clones were selected
for their growth capacity through a phenotypic screen (2 cm-
long roots or higher). Hairy root clones having stably
integrated the human IDUA transgene were selected through
a PCR analysis on hIDUA transcripts using specific primers for
IDUA and the SEC61 gene, which is constitutively expressed in
Brassica species [UniProtKB - P0DI74 (S61G1_ARATH)] (Fig-
ure 1a). After this selection step, the ability of the selected
hairy root clones to produce and secrete an active recombi-
nant a-L-iduronidase protein into the media was assessed. As
shown in Figure 1b, productivity observed for clone 84 was
outstanding as compared to the others. This best producing
clone was finally selected for further analyses based on the
activity assay screening. The immunodetection analysis of the
culture medium from this selected hairy root clone using an
anti-IDUA antibody shows a band at a molecular weight of
nearly 80 kDa. According to the fact that the molecular
weight of the mature non glycosylated protein is theoretically
expected to be 70.77 kDa, this result confirmed the presence
of the protein of interest in the culture medium under a
glycosylated form (Figure 1c). This analysis was done using the
crude culture medium harvested from several bioreactors
cultured from the same hairy root clone (clone 84) showing a
remarkable batch-to-batch reproducibility of the production of
rIDUA_RLT protein by the selected clone (Figure 1c). Finally,
the identity of the protein of interest was further validated by
a proteomic approach combined to MS2 from crude culture
medium. This analysis displayed a 68.5% peptide recovery as
compared to the theoretical sequence of the expressed IDUA
(Figure 1d).
The rIDUA_RLT protein (Figure 2a) was then purified using a
two chromatographic step protocol. A protein purity degree of
over 96% (Figure 2b) without any soluble aggregate as estimated
by SE-HPLC and RP-HPLC was obtained (Figure 2c; see Data S1).
The N-terminal sequence of rIDUA_RLT corresponds to
the expected sequence, demonstrating that the signal
peptide was efficiently removed
For the recombinant protein to be secreted within the culture
medium, a gene sequence encoding for a specific signal
peptide already used in (Ele Ekouna et al., 2017; Huet et al.,
2014) was added to the 50 end of the nucleotide sequence.
This signal peptide has to be removed during the secretion
step, in the endoplasmic reticulum as normally observed in
eukaryotic cells (Dudek et al., 2015; Kober et al., 2013;
Zimmermann et al., 2011). To validate the absence of the
signal peptide in the protein secreted by the hairy roots based
expression platform, a N-terminal sequencing using Edman
degradation was performed (data not shown). A N-terminal
MAXXV pentapeptide was identified with X being a modified
amino acid. Considering that the expected N-terminal pen-
tapeptide is MAPPV, this analysis suggested that cleavage of
the signal peptide occurred as expected before the Met 24.
This demonstrates the efficiency of the hairy root expression
system to recognize and cleave successfully the signal peptide
of heterologous proteins.
rIDUA_RLT protein exhibits enzymatic kinetics that are
comparable with the ones displayed by the same
enzyme produced in CHO cells
The kinetic parameters of the purified rIDUA_RLT protein
produced were measured. Michaelis-Menten kinetics were used
to characterize the enzymatic properties of the rIDUA_RLT protein
in comparison with the commercially available recombinant
protein produced in CHO cells (Aldurazyme, Sanofi). rIDUA_RLT
displays a Vmax of 8.5 lmol/min/mg, a kcat of 11.8 s1 and a
Km of 120 lM, whereas Aldurazyme, analysed in parallel within
the same experiment, exhibited a Vmax of 6.8 lmol/min/mg, a
kcat of 9.4 s1 and a Km of 130 lM. These results show that
rIDUA_RLT and Aldurazyme have comparable enzymatic activity
and affinities towards the same substrate (Figure 3). The enzy-
matic activity being usually related to the protein quality and
glycosylation, it was of interest to biochemically characterize the
rIDUA_RLT protein and focus especially on its glycosylation
profile.
N-Glycosylation analysis indicates that rIDUA_RLT
protein displays a highly homogeneous paucimannosidic
profile
The N-glycan profile of rIDUA_RLT has been determined by mass
spectrometry analysis of oligosaccharides released from the
purified recombinant enzyme (Figure 4). The only ion that can
be assigned to glycan residues is the ion at m/z 704.81which
corresponds to a N-glycan composed of a core Man3GlcNAc2
carrying one beta(1,2)-xylose and one alpha(1,3)-fucose epitope
(M3XFGN2), a N-glycan widely described in plants (Bardor, 2008;
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Figure 1 (a) Example of transgene expression detection by RT-PCR. (Top gel) PCR detection of the IDUA transgene expression from total RNA extracted
from different hairy root clones. (+) pRD400 plasmid with IDUA gene was used as positive control, () RNA extract of wild type hairy root clone (without
any transfection) was used as negative control (Bottom gel) PCR detection of a gene constitutively expressed in Brassica: SEC61 (endoplasmic reticulum
membrane protein translocator) (+) RNA extract of wild type hairy root (without any transfection) was used as positive control, () pRD400 plasmid with
IDUA gene was used as negative control, numbers designating clones, DNA ladder in base pair (bp). (b) Normalized productivity (U/L/g dried weight) in
percentage related to the best producing clone, namely clone 84. (c, d) Identification of rIDUA_RLT in crude culture media by (c) Western blot analyses of
equivalent amounts of four different batches (161, 163, 164, 165) of the selected hairy root clone 84 in comparison with a commercial standard protein
(ABIN1464142, Antibodies-online) in increasing amount (250, 500, 750, 1000 ng), (d) Mass spectrometry analysis of rIDUA_RLT. The identified peptides
are highlighted in grey on the amino acid sequence.
Figure 2 (a) Silver stained SDS-PAGE gel of crude culture media from a wild type (WT) hairy-root clone (hairy root clone without any integrated transgene)
and the selected hairy root clone 84. Red arrow points out the rIDUA_RLT (b) Silver stained SDS-PAGE gel of the purified rIDUA_RLT protein (100, 50 and
10 ng of rIDUA_RLT) and 50 ng of positive control C+ (ABIN1464142, Antibodies-online) (c) SE-HPLC profile of the purified rIDUA_RLT protein. The purity
of the rIDUA_RLT is of 96.2% without any soluble aggregates.
ª 2018 The Authors. Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists and John Wiley & Sons Ltd., 17, 505–516
hIDUA produced in Brassica rapa hairy root 507
Brooks, 2011; Schoberer and Strasser, 2017). The other ions
correspond to non-glycan contaminants. A unique paucimanno-
sidic N-glycan was thus detected. These results were also
confirmed using western blot against beta(1,2)-xylose and alpha
(1,3)-fucose (data not shown). In order to determine the
distribution of this oligosaccharide on each N-glycosylation site
of the recombinant rIDUA_RLT secreted by the hairy root clones,
a glycoproteomic approach combined to nano LC-nanoESI-MS
was used as previously described (Vanier et al., 2015). This has
made it possible to access both to the N-glycan structures and to
their site-occupancy. For that, LC peaks giving MS2 spectra
exhibiting N-glycan diagnostic fragment ions at m/z 204 (N-
acetylglucosamine), 163 (mannose) and 366 (Man-GlcNAc) were
assigned to glycopeptides (Figure 5a). Using such assignment and
as illustrated in Figure 5a, M3XFGN2 N-glycan was identified
attached to each of the 6 N-glycosylation sites. Sequences of
glycopeptides were then confirmed by analysis of the fragmen-
tation patterns obtained by MS2 (Figure 5b). The Figure 5
exemplifies the results obtained from the analysis of the
rIDUA_RLT produced in one bioreactor batch.
A deglycosylation experiment definitively confirmed that all N-
glycosylation sites of the rIDUA_RLT protein are occupied. Indeed,
non-glycosylated peptides containing an Asn residue were not
detected in the rIDUA_RLT which indicates that the six sites are
fully N-glycosylated. Thus, this result indicates that this hairy root
based platform is able to N-glycosylate efficiently the complex
recombinant proteins.
O-glycosylation analysis of rIDUA_RLT produced in the
hairy root based expression platform
Like N-linked glycans, O-linked glycans play an important role in
protein stability and function (Kim et al., 2016; Zhang et al.,
2013). In order to further characterize the glycosylation profile of
the rIDUA_RLT protein produced, an analysis of its O-glycosyla-
tion profile was performed.
As mentioned above, the N-terminal sequencing using Edman
degradation displayed a MAXXV sequence at the N-terminal end
of the rIDUA_RLT protein. It thus appears that the X residues in
the rIDUA_RLT protein may correspond to proline residues that
experienced post-translational modifications. To investigate
which modifications may occur on the proline residues at the
N-terminal extremity of the rIDUA_RLT protein, a nano LC-
nanoESI-MS analysis of the recombinant rIDUA_RLT was carried
out as described above after tryptic digestion of the recombinant
protein. Native N-terminal MAPPVAPAEAPHLVHVDAAR tryptic
peptide was not found. However, N-terminal peptides were
detected with m/z shifts of 16, 32 and 48 mass units. The
sequences of these N-terminal peptides were investigated by MS2
sequencing. MS2 spectrum of the double charged ion corre-
sponding to the N-terminal peptide exhibiting a m/z shift of 32
mass units is presented in Figure 6. The fragmentation pattern
indicated that the m/z shift is carried out by the N-terminal
MAPPV amino acid sequence. Considering the absence of
detection of proline residues in the N-terminal Edman degrada-
tion, we thus conclude that these two proline residues are
hydroxylylated in the rIDUA_RLT produced in B. rapa hairy roots.
As well, peptides with m/z shifts of 16 and 48 mass units were
assigned to N-terminal sequences containing one and three
hydroxyproline residues, respectively. Based on the ion intensity,
the relative percentage of the N-terminal peptide bearing one
hydroxyproline is about 40%, the one of the peptide bearing two
hydroxyproline residues represent almost 60% and N-terminal
peptide containing 3 hydroxyproline residues represent about
1%.
In addition to m/z shifts resulting from the hydroxylation of
proline residues, N-terminal MAPPVAPAEAPHLVHVDAAR tryptic
peptides with m/z shifts of 132 or 264 and representing about
1% of the overall peptide population were also detected. These
peptides may result from the transfer of pentose residues onto
hydroxyproline residues as observed in plants (Schoberer and
Strasser, 2017). To determine which pentose may be linked to
hydroxyproline residues, a monosaccharide composition of
rIDUA_RLT was determined by gas chromatography analysis
(Table 1). Xylose, fucose, GlcNAc and mannose were detected
which is consistent with the N-glycosylation profile of this protein
as depicted in Figures 4 and 5. In addition, arabinose residues,
and no other pentose, were also detected suggesting that the
pentose O-linked to hydroxyproline is indeed arabinose (Table 1).
Glucose and galactose are contaminant residues.
A second peptide containing a PPXP sequence (peptide
STGFCPPLPHSQADQYVLSWDQQLNLAYVGAVPHR) was identified
as being hydroxylated. One to three hydroxylations were detected
on this peptide by LC-ESI-MS. In addition to mono-, di- and
trihydroxylated forms of the peptide, a tetrahydroxylated variant
was also detected by nanoLC-nanoESI-MS.
N/O-glycosylation homogeneity and reproducibility of
rIDUA_RLT
Using the same analytical strategy, searches for other posttrans-
lational modifications, such as phosphorylation of hydroxy
aminoacids, were unsuccessful. In addition, similar results were
obtained on the analysis of the N- and O-glycosylation of the
Figure 3 (a) Michaelis-Menten curves and (b) Lineaweaver-Burk kinetic assay plots for Aldurazyme and the recombinant IDUA produced in transgenic
turnip hairy roots (rIDUA_RLT). (c) Kinetic parameters of Km and Vmax values are an average of three independent experiments  SD.
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rIDUA_RLT protein produced at 6-month intervals in two inde-
pendent bioreactor batches (data not shown). On each of the 6
N-glycosylation sites of both rIDUA_RLT proteins produced using
the two independent bioreactor batches, a single N-glycan
composed of a core Man3GlcNAc2 carrying one beta (1,2)-xylose
and one alpha(1,3)-fucose epitope (M3XFGN2) was identified.
Moreover, the same hydroxylation and arabinosylation modifica-
tions were identified on both rIDUA_RLT during O-glycosylation
analysis. These results indicate that expression of rIDUA_RLT in
hairy roots is robust and reproducible not only in term of protein
productivity (Figure 1c) but also in term of N- and O-glycosylation
profiles.
Discussion
In the present work, the ability of the B. rapa hairy root based
expression platform to produce and secrete a complex recombi-
nant glycoprotein in its active form was demonstrated taking as
an example the rIDUA_RLT protein. This highlights the relevance
of the platform as an expression system. It was shown that the
hairy-root based rIDUA_RLT protein shows enzymatic character-
istics similar to the ones of the same recombinant protein
produced in CHO (Aldurazyme) despite the differences that exist
between both expression systems in terms of post-translational
modifications.
The N-glycosylation analysis of rIDUA_RLT showed that the
recombinant protein displays a single paucimannose profile on all
N-glycosylation sites. Such a homogeneity is remarkable because
in most expression systems commonly used for the production of
biopharmaceuticals, N-glycosylation of recombinant proteins
carry multiple N-glycan structures resulting from the variability
of N-glycan maturation occurring in the Golgi apparatus. This
results in recombinant therapeutic proteins exhibiting high
heterogeneity which may affect the batch-to-batch reproducibil-
ity (Hossler et al., 2009; Lingg et al., 2012). As an example,
Aldurazyme, the rIDUA protein produced in CHO cells, is
characterized by a high intra-site heterogeneity of the N-linked
glycans and this was observed in each of the six N-glycosylation
sites (Zhao et al., 1997). Indeed, the site specific glycosylation
pattern that characterize Aldurazyme is: Asn-110, complex type
glycans; Asn-190, complex type glycans; Asn-336, bisphosphory-
lated oligomannosidic glycan (P2Man7GlcNAc2); Asn-372, high
mannose type glycans (mainly Man9GlcNAc2, some of which are
monoglucosylated); Asn-415, mixed oligomannosidic and com-
plex type glycans; Asn-451, bisphosphorylated oligomannosidic
glycan (P2Man7GlcNAc2; Zhao et al., 1997); which contrasts
with the single paucimmanose profile found in all N-glycosylation
sites of rIDUA_RLT. Similarly, the recombinant IDUA proteins
produced in other plant-based expression systems than the hairy
roots are characterized by a heterogeneity of the N-glycosylation
profiles with nevertheless a predominance of high mannose
profiles (He et al., 2012, 2013). The absence of such a large
heterogeneity when analysing the N-glycosylation profiles of the
rIDUA_RLT produced using the B. rapa hairy root system is of
particular interest at a regulatory level to increase the repro-
ducibility of the batches that may be used in clinical trials.
Such observation was also made when analysing total endoge-
nous proteins of B. rapa hairy root clones developed using the
hairy root platform. As an example, total endogenous proteins
from isolated young or old roots collected at different time-points
of the culture of hairy root clones expressing the glucocerebrosi-
dase (GCD) recombinant protein still essentially display profiles of
paucimannosidic type (see Data S1 and Figure S1) when analysed
by mass spectrometry, reinforcing our observation. High-man-
nose N-glycans were not detected in the oligosaccharide profile.
We postulate that B. rapa Golgi a-mannosidases are likely highly
efficient in the processing of high-mannose N-glycans arising
from Endoplasmic Reticulum biosynthesis steps into mature
glycans. These additional observations reinforce the demonstra-
tion of the ability of the B. rapa hairy root platform to produce
recombinant proteins with a remarkable homogeneous glycosy-
lation profile, never observed in the recombinant proteins
produced in CHO (Tekoah et al., 2013; Zhao et al., 1997).
As in mammals, plants can also produce proteins displaying
O-glycosylation profiles (Tekoah, 2006). However, the O-glyco-
sylation profiles of the recombinant proteins produced from
plant-based expression systems were only poorly described in the
literature (Karnoup et al., 2005; Kim et al., 2016; Schoberer and
Strasser, 2017). O-linked glycosylation can be found in amino
acids that contain a hydroxyl group (i.e. serine, threonine,
Figure 4 ESI mass spectrum of N-glycans isolated from rIDUA_RLT and coupled to procainamide. Ion at m/z 704.81 was assigned to the doubled charged
[M + 2H]2+ M3XFGN2. Other ions correspond to non-glycan contaminants. M, mannose; X, xylose; F, fucose; GN, N-acetylglucosamine.
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Figure 5 (a) nano ESI mass spectra of LC peaks from digested rIDUA_RLT with MS2 spectra exhibiting N-glycan reporter fragment ions at m/z 204, 163
and 366. In each MS spectrum, glycopeptide exhibits different charge states (z = 2 or 3). In the peptide sequence, asparagine residue (N) of the N-
glycosylation site is underlined. (b) MS2 fragmentation spectrum of the double charged [M + 2H]2+ glycopeptide 3 at m/z 1636.27 as illustration. For
M3XFGN2 structure, see Figure 4. M, mannose; X, xylose; F, fucose; GN, N-acetylglucosamine.
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hydroxyproline and hydroxylysine). Hydroxylation of the proline
amino acids takes place in the Endoplasmic Reticulum, then O-
glycosylation occurs in the Golgi apparatus (Schoberer and
Strasser, 2017). In our study, hydroxylation and O-glycosylation
of proline residues have been highlighted on rIDUA_RLT. Such
hydroxylation was already observed in the recombinant IDUA
protein produced in CHO (Jung et al., 2013). However, to the
best of our knowledge, no analysis of the O-glycan profiles
associated with this protein was further investigated although this
mechanism is indeed present in mammals. O-glycosylation has
also been described in plants, where it converts the proline
residues to hydroxyproline and attaches arabinose residues to
recombinant proteins (Karnoup et al., 2005; Pinkhasov et al.,
2011). In the monosaccharide composition of rIDUA_RLT, in
addition to xylose of N-glycans, only one pentose, arabinose, was
observed suggesting that the m/z shifts of 132 of hydroxyproline-
containing peptides are indeed due to arabinose attachment.
Finally, the rIDUA_RLT presents a similar glycan profile as the
one classically observed in proteins produced by other plant-
based expression systems, in particular the well-characterized
beta(1,2)-xylose and one alpha(1,3)-fucose epitopes. These
residues have been criticized likely as being immunogenic (Bardor
et al., 2003). However, this observation is still controversial and
depends on the studied model. Elelyso, a recombinant GCD
produced using carrot cells by Protalix (Carmiel, Israel) and used in
clinic since 2012 is a good example of the non-toxicity of such
glycoepitopes. Indeed, Elelyso is characterized by the presence of
the plant-specific residues, i.e. beta(1,2)-xylose and alpha(1,3)-
fucose. In addition, signals consistent with the presence of
arabinose were detected in the monosaccharide composition of
the carrot cells-produced GCD (Shaaltiel et al., 2015). Neverthe-
less, no adverse effect was observed that could be linked to such
particular residues in all patients treated so far using this
therapeutic product, neither during the clinical trials, nor since
its approval by the regulatory authorities. This plant-based protein
appeared as safe as the treatment of the patients using the
counterpart protein produced in CHO (Cerezyme/Sanofi) or
human fibroblast cells (VPRIV/Shire Dublin, Ireland; Shaaltiel and
Tekoah, 2016). The glycosylation profile of the recombinant
proteins produced using the B. rapa hairy root platform could be
thus compatible with a therapeutic use of such proteins.
Finally, thanks to the highly homogeneous paucimannosidic
profile of its recombinant proteins, the B. rapa hairy root based
expression platform is of particular relevance for the production of
proteins of therapeutic interest such as the GCD for the treatment
of Gaucher disease or the alpha galactosidase for the treatment of
the patients with Fabry disease. Regarding the treatment of other
lysosomal disorders, the addition of mannose-6-phosphate (M6P)
residues would be ideally required in vivo as the plants are not
naturally able to phosphorylate the mannose residues. Several
strategies are described in the literature allowing the addition of
such residues on plant-based recombinant proteins (He et al.,
2012, 2013). The existence of alternate M6P-independent path-
ways for lysosomal enzyme sorting has also been largely described
(Markmann et al., 2015). As an example, based on Kakkis results
(Kakkis et al., 1994), 20% of the IDUA protein is able to penetrate
the targeted cell through an alternative pathway to the well-
characterized M6P recognition system. This independent glycosy-
lation pathway can be related to the usage of alternatives routes
enabling recombinant proteins to penetrate the targeted cells such
as the use of HIV Tat peptides (Xia et al., 2001; Zhang et al., 2008),
insulin growth factor II (LeBowitz et al., 2004), receptor associated
protein RAP (Prince et al., 2004), insulin receptor (Boado et al.,
2008, Lu et al., 2011), intercellular adhesion molecule 1 (ICAM-1;
Hsu et al., 2011, Hsu et al., 2012, Muro et al., 2006), transferrin
receptor (Tfr; Chen et al., 2008, Osborn et al., 2008), RTB lectin
(Acosta et al., 2015).
As an example, an a-glucosidase (GAA) recombinant protein,
enzyme involved in Pompe disease, coupled to polymer nanocar-
riers coated with an antibody specific to ICAM-1, allowed the
efficient internalization and lysosomal transport of GAA into
target cells enhancing substrate degradation (Hsu et al., 2012). In
the same way, a galactocerebrosidase tagged with HIV Tat
protein facilitated its uptake into neurons using M6P independent
pathway (Zhang et al., 2008). More recently, Sonoda et al.
(2018) showed that the recombinant iduronate-2-sulphatase
fused with an anti-TfR antibody was able to be uptaken by
fibroblastes through both the TfR and the M6P pathways. All
Figure 6 MS2 fragmentation spectrum of the double charged [M + 2H]2+ MAPPVAPAEAPHLVHVDAAR N-terminal peptide (m/z 1049.03) containing two
hydroxyproline residues.
Table 1 Monosaccharide composition of alpha-L-iduronidase
produced in Brassica rapa hairy roots
Monosaccharide Relative molar composition %
Arabinose (Ara) 7.2
Fucose (Fuc) 5.3
Xylose (Xyl) 7.6
Mannose (Man) 39.3
Galactose (Gal) 18.7
Glucose (Glc) 2.1
N-acetylGlucosamine (GlcNAc) 19.8
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these examples show that several alternative strategies can be
used to enhance the uptake of recombinant lysosomal enzymes,
including alpha-L-Iduronidase, even if the N-glycan phosphoryla-
tion is lacking in these recombinant proteins.
Material and methods
Materials
Escherichia coli strain JM101 and R. rhizogenes strain ICPB TR7were
used for cloning and plant transformation, respectively, and B. rapa
rapa cv ‘Navet des vertus marteau’ for hairy root production. Plant
tissue culture media, vitamins and sucrose came from Duchefa
Biochemie. 4-methylumbelliferyl-a-L-Iduronide (4MU-I) came from
Santa Cruz Biotechnology (Dallas, TX). The commercial recombinant
IDUA protein used as positive control came from Antibodies-online.
The anti-IDUAantibody used in theWestern-blot analyses came from
Antibodies-online. All reagents used to study the post-translational
modifications of the IDUA protein were of HPLC grade. Peptide N-
Glycosidase A was purchased from Roche Mannheim, Germany. All
reagents used for SDS-PAGE silver staining, -Methylumbelliferone
(4MU) andConcanavalin Awere purchased from Sigma (Saint-Louis,
MO). Antibodies directed against the anti-xylose and anti-fucose
epitopes were from Agrisera V€ann€as, Sweden.
Molecular cloning
Gene synthesis of the human Iduronidase A (IDUA) (NCBI NP_
000194.2) coding sequence was performed by GeneART
(ThermoFisher Scientific, Regensburg, Germany) including the
Tobacco Mosaic Virus (TMV) omega translational enhancer, the
signal peptide (SP) coding sequence from the Arabidopsis
At1g69940pme gene and the HindIII and EcoRI restriction sites
for easy subcloning into the previously described pJIT163 plasmid
(Guerineau, 1995). The expression cassette containing the omega
translational enhancer, the SP and the IDUA sequence was cloned
into HindIII/EcoRI restriction sites of the binary plant expression
vector pRD400 (Datia et al., 1992) containing an upstream 35S
Cauliflower Mosaic Virus (CaMV) promoter and a downstream
CaMV 35S terminator. The pRD400 vector was then inserted in
R. rhizogenes bacteria.
Transgene expression detection
Total RNA extracts from 0.1 g transformed fresh roots were
prepared with the kit Total RNA and Protein Isolation (Macherey-
Nagel, D€uren, Germany). 0.1 lg/lL of total RNA extracts were
used to generate the cDNA by using the M-MuLV Reverse
Transcriptase (New England Biolabs, Ipswich, MA). The cDNA was
then amplified using the specific primers: 50-TTCTGTCCTCCTC
TCCCTCA-30, 50-AGGGACCTCTAAGTACGGCA-30 for hIDUA and
50-ATTCCGTCGTCGATCCTCT-30, 50-ACCGACGATGATGTTGTTG
A 30 for SEC61.
Plant transformation and hairy root culture
Turnip plants were transformed as described in (Huet et al.,
2014). Briefly, after 10 days growth, the elongated stems
originating from the culture of Turnip (B. rapa L. var. rapa
cv. des vertus marteau) seeds were infected using the R. rhizo-
genes prepared as described above. The roots emerging from the
infection sites were individualized and placed on medium B5
Gamborg (Gamborg et al., 1968). Isolated root lines were
screened according to their growth capacity and their ability to
produce the rIDUA_RLT protein by Western-blot analysis. The
culture was carried out as described previously (Ele Ekouna et al.,
2017). For pilot scale production, root clones were cultured in
25 L airlift bioreactors.
Protein analysis
Western blot
Samples (crude culture media) were resolved in AnykD mini
protean TGX polyacrylamide gels (Bio-Rad). For Western blot
analysis, proteins were transferred to nitrocellulose membranes
(Bio-Rad, Hercules, California) using the Bio-Rad Turbo Trans-Blot
system. The membranes were blocked in 5% fat-free milk
(Blotting grade blocker, Bio-Rad) in TBS buffer, incubated with a
1:1000 dilution of the mouse anti-a-L-Iduronidase (ABIN603316
from Antibodies-online) followed by a 1:5000 dilution of a goat
anti-mouse IgG-HRP antibody (sc-2005 from Santa Cruz Biotech-
nology). Staining was developed using Western Clarity ECL
revelation kit (170-5060, Bio-Rad).
Silver staining of proteins in polyacrylamide gels
Samples (crude culture media) or purified protein were resolved in
AnykD mini protean TGX polyacrylamide gels (BioRad). For silver
stain, gels were incubated in 50% ethanol/10% acetic acid
during 30 min, then in 30% ethanol/1% acetic acid for 15 min.
Gels were washed in ultrapure H2O with shaking, three times for
10 min. Gels were sensitized during 90 s in 0.02% sodium
thiosulphate, 6.8% sodium acetate then rinsed in H2O. Gels were
incubated in 0.1% silver nitrate for 10 min. Gels were incubated
in 3% sodium carbonate, 0.0002% sodium thiosulphate and
0.025% formaldehyde with shaking during 1 min. Revelation
were stopped with a 40 mM EDTA-Na2 solution for 5 min.
MS analysis
For nanoLC/MS/MS analysis, samples were prepared as described in
(Allmann et al., 2014). The peptides were analysed on an Ultimate
3000 RSLC Nano-UPHLC system (Thermo Scientific, Waltham,
Massachusetts) coupled to a nanospray Q-Exactive hybrid quadru-
pole-Orbitrapmass spectrometer (Thermo Scientific). Tenmicroliters
of each peptide extract were loaded onto a 300 lm ID 9 5 mm
PepMap C18 pre-column (Thermo Scientific) at a flow rate of
20 lL/min. After 5 min desalting, peptides were separated on a
75 lm ID 9 25 cm C18 Acclaim PepMap RSLC column (Thermo
Scientific) with a 4%–40% linear gradient of solvent B (0.1% formic
acid in 80%CH3CN) in 108 min. The separation flow ratewas set at
300 nL/min. The mass spectrometer was operated in positive ion
modeat aneedle voltageof 1.8 kV.Datawere acquiredusingXcalibur
3.1 software in a data-dependent mode. MS scans (m/z 350–1600)
were recorded at a resolution ofR = 70 000 (@m/z 200) and anAGC
target of 3 9 106 ions was collected within 100 ms. Dynamic
exclusion was set at 30 s and the top 12 ions were selected from
fragmentation in HCD mode. MS/MS scans with a target value of
1 9 105 ionswere collectedwith amaximumfill timeof 100 msanda
resolution of R = 17 500. Additionally, only +2 and +3 charged ions
were selected for fragmentation. Other settings were as follows: no
sheath and no auxiliary gas flow, capillary heated at 200 °C,
normalizedHCD collision energy of 27%and isolationwidth of 2 m/z.
Mascot, Sequest and Amanda algorithms through Proteome
Discoverer 1.4 Software (Thermo Fisher Scientific Inc.) were used
for protein identification in batch mode by searching against a
merge of protein databases: UniProt Arabidopsis thaliana
database (31 587 entries, Reference Proteome Set, release
2015_01) and UniProt Brassica Rapa subsp. pekinensis database
(40 809 entries, release 2015_01) from http://www.uniprot.org/
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website and the sequence of the recombinant protein. Two
missed enzyme cleavages were allowed. Mass tolerances in MS
and MS/MS were set at 10 ppm and 0.02 Da. Peptide validation
was performed using the Percolator algorithm (Kall et al., 2007)
and only high confidence peptides were retained corresponding
to a 1% False Positive Rate at peptide level.
rIDUA_RLT purification
Culture medium was collected, clarified by centrifugation at
9000 g for 20 min at 4 °C and filtered through two successive
steps using a 0.8–0.45 lm and a 0.45–0.2 lm filters (Sartopore 2
Midicap). The fraction was applied on the strong cation
exchanger chromatography Eshmuno S from Millipore equili-
brated with sodium acetate 100 mM, urea 1.5 M, pH 5.0 followed
by the same buffer without urea 1.5 M. The elution step was
performed at 25 mS/cm with 20% (v/v) sodium acetate 100 mM,
NaCl 1 M pH 5.0 followed by a step at 34 mS/cm with 30% (v/v)
of the same buffer. The fractions containing the rIDUA_RLT
protein were collected and applied on a hydrophobic interaction
chromatography (HIC) resin Toyopearl Phenyl 650 M from Tosoh
equilibrated with 20 mM sodium phosphate, pH 7.0 with and
without 3 M NaCl. The first step of elution was performed with
30% (v/v) of 20 mM sodium phosphate containing 3 M NaCl pH
7.0. A gradient from 35% to 100% of sodium phosphate 20 mM,
NaCl 3 M pH7.0 was then applied in order to recover the
rIDUA_RLT protein. The pooled fractions containing rIDUA_RLT
were concentrated using a membrane cut-off of 30 kDa (Sarto-
con cassette PES – Sartorius, G€ottingen, Germany) and submitted
to a diafiltration using 10 volumes of buffer NaH2PO4.2H2O
92 mM, Na2HPO4.12H2O 8 mM, NaCl 150 mM, pH 6.0 to achieve
a protein concentration of 0.58 mg/L. Tween 80 was finally
added to achieve a final concentration of 10 mg/L. The material
collected from the formulation step was submitted to a 0.2 lm
filtration using a Minisart PES filter, aliquoted and stored at
20 °C. Quality of the purified material and concentration of the
pure enzyme was determined by SDS-PAGE, western-blot, SE-
HPLC and RP-HPLC.
SE-HPLC analysis
The purity level of IDUA protein as well as the presence of soluble
aggregates were analysed using a SE-HPLC method performed on
a HPLC Agilent system (HPLC Agilent Series 1200 Infinity)
equipped with a refrigerated autosampler, a quaternary pump,
a column heater and a DAD detector. A volume of 100 lL of
sample was injected onto a Superdex 200 Increase 10/300
column (GE). The mobile phase was PBS, pH 7.2 buffer (NaCl,
8 g/L, KCl 0.2 g/L, Na2HPO4.12 H2O 3.58 g/L, KH2P04 0.24 g/L).
The flow rate was 0.5 mL/min. The SE-HPLC profile was recorded
at 280 nm.
Determination of the human a-L-Iduronidase activity
Turnip hairy root culture media coming from transformed hairy
root cultures as well as the purified rIDUA_RLT protein were
used to determine the activity of the recombinant protein of
interest by using the fluorogenic substrate sodium 4-methy-
lumbelliferyl-a-L-Iduronide (4MU-I; Santa Cruz Biotechnology)
as described in (Ou et al., 2014). The 4MUI substrate was
diluted to a working solution of 400 lM 4MU-I with the reaction
buffer 0.4 M sodium formate, pH 3.5. Twenty-five lL of sample
were added to 25 lL of 400 lM 4MU-I substrate. The mixture
was incubated at 37 °C for 30 min and 200 lL glycine
carbonate buffer (pH 9.8) was added to quench the reaction.
4-Methylumbelliferone (4MU) (Sigma) was used to prepare the
standard calibration curve. Fluorescence was measured using a
plate reader (TECAN Infinite M1000, M€annedorf, Switzerland)
with excitation at 355 nm and emission at 460 nm. IDUA
enzyme activity was expressed in units (lmol converted to
product per minute) per sample volume (millilitres). The
parameters KM, kcat and Vmax were calculated by linear fit on
a Lineweaver-Burk plot (Ou et al., 2014).
Determination of the N-Terminal sequence
The rIDUA_RLT produced and purified from hairy roots culture
medium was separated by an 8% SDS-PAGE, and then trans-
ferred to a PVDF membrane using the ProSorb system from
Applied Biosystems. N-terminal sequence was then determined
automatically by Edman degradation with the Procise P494
(Applied Biosystem, Foster City, California).
Analysis of the glycosylation of the purified rIDUA_RLT
Identification of the total N-glycan profile of rIDUA_RLT
rIDUA_RLT was digested with proteases prior to a deglycosylation
using the PNGase A as previously described (Ba€ıet et al., 2011,
Mathieu-Rivet et al., 2013). Released N-glycans were then
purified over C18 and PGC pre-packed columns (Bakker et al.,
2001, Ho et al., 2012). Finally, labelling of the purified N-glycans
to procainamide (proc) was carried out by reducing amination
according to the manufacturer instructions (Ludger LTD, Culham,
Oxfordshire, UK LudgerTag Procainamide Glycan Labeling Kit).
Procainamide derivatized N-glycans were then analysed by
nanoLC coupled to nanoESI-MS using the nano-LC1200 system
coupled to a QTOF 6520 mass spectrometer equipped with a
nanospray source and a LC-Chip Cube interface (Agilent Tech-
nologies, Santa Clara, California).
Sample preparation
Purified rIDUA_RLT was separated on a NuPAGE Bis-Tris gel
electrophoresis. Band corresponding to rIDUA_RLT was excised
from the gel and cut into pieces. Gel pieces were washed several
times with a solution mixture composed of 0.1 M NH4HCO3 pH 8
and 100% CH3CN (v: v). Samples were dried down in a SpeedVac
centrifuge (Thermo Fisher). After a reduction step with 0.1 M
dithiothreitol (DTT) for 45 min at 56 °C and alkylation with
55 mM iodoacetamide (IAA) for 30 min at room temperature in
the dark, proteomic-grade trypsin was added (1 lg per protein
band; Promega) and placed at 4 °C during 45 min prior to an
overnight incubation at 37 °C. Then, rIDUA_RLT was eventually
submitted to an additional chymotrypsin digestion. After protease
digestion, gel pieces were incubated subsequently in a 50%
CH3CN solution, 5% formic acid solution, 0.1 M NH4HCO3,
100% CH3CN and finally in 5% formic acid to extract the
resulting peptide and glycopeptide mixture.
Protein identification and site-specific distribution of N- and
O-glycans
MS analyses were performed using the nano-LC1200 system
coupled to a QTOF 6520 mass spectrometer equipped with a
nanospray source and a LC-Chip Cube interface (Agilent
Technologies). Briefly, peptide and glycopeptide mixture was
enriched and desalted on a 360 nL RP-C18 trap column and
separated on a Polaris (3-lm particle size) C18 column (150 mm
long 9 75 lm inner diameter; Agilent Technologies). A 33-min
linear gradient (3%–75% acetonitrile in 0.1% formic acid) at a
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flow rate of 320 nL/min was used, and separated peptides were
analysed with the QTOF mass spectrometer. Full auto MS scans
from 290 to 1700 m/z and auto MS2 from 59 to 1700 m/z were
recorded. In every cycle, a maximum of 5 precursors sorted by
charge state (2+ preferred and single-charged ions excluded)
were isolated and fragmented in the collision cell. Collision cell
energy was automatically adjusted depending on the m/z. Scan
speed raise based on precursor abundance (target 25 000
counts/spectrum) and precursors sorted only by abundance.
Active exclusion of these precursors was enabled after three
spectra within 1.5 min, and the threshold for precursor selection
was set to 1000 counts. Glycopeptides were selected in the LC
profile by selecting MS2 spectra exhibiting N-glycan diagnostic
fragment ions at m/z 204 and 163. Mass hunter qualitative
analysis version B.07 (Agilent Technologies) was used to analyse
the spectra.
In order to evaluate the site occupancy, IDUA peptides and
glycopeptides mixture was deglycosylated by using the peptide N-
glycosidase A (PNGase A; Roche diagnostic) according to (Vanier
et al., 2015).
Monosaccharide composition using gas chromatography
The monosaccharide composition was determined by gas chro-
matography using 100 nmol of inositol as internal standard.
rIDUA_RLT was hydrolysed during 2 h in 2 M TFA (trifluoroacetic
acid) at 110 °C. Freeze-dried samples were methanolysed with
dry 1 M methanolic-HCl (Supelco) for 16 h at 80 °C and then
were dried under a stream of nitrogen and washed twice with
methanol. Re-N-acetylation step was performed in methanol/
pyridine/acetic anhydride 4:1:1 (Sigma) for 1 h at 110 °C. The
resulting methyl sugars were treated with HDMS (hexamethyld-
isilazane)/TMCS (trimethylchlorosilane)/pyridine solution (3:1:9,
Supelco), for 20 min at 110 °C. Trimethylsilylated monosaccha-
rides were dried and dissolved in 1 mL of cyclohexane. One ll of
sample was separated by gas chromatography on a
0.25 mm 9 25 m silica capillary column of CP-Sil 5 CB with
helium as a carrier gas and detected with a flame ionization
detector. Neutral sugar standards (L-arabinose, L-fucose,
D-galactose, D-mannose, D-galacturonic acid, L-rhamnose,
D-glucose, D-GlcNAc, and D-xylose) were processed in parallel
to the samples. Assignment of sample peaks was carried out by
comparison of their retention times with those of standards
treated and analysed in parallel.
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